India's Pharmaceutical Exports

Country Profile

Cayman Islands

Cayman Islands is a developing market for Indian pharmaceuticals — $7.74M in FY 2025–26, with 7.3× growth over the past decade. Medicines accounts for 67% of shipments, with vaccines contributing $39K. The compound annual growth rate since FY2016 stands at 22.0%.

🇰🇾 $7.74M · 7.3× growth since FY2016 · 22.0% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$7.74M
Exports FY2025–26 DGCIS
7.3×
Growth FY2016→2026
22.0%
CAGR FY2016→2026
67%
Medicines Share
4
Product Categories Supplied
Cayman Islands is a developing market for Indian pharmaceuticals — $7.74M in FY 2025–26, with 7.3× growth over the past decade. Medicines accounts for 67% of shipments, with vaccines contributing $39K. The compound annual growth rate since FY2016 stands at 22.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $5.17M (66.9%) Surgical & Hospital Supplies $2.45M (31.7%) Traditional & Herbal $74K (1.0%) Vaccines $39K (0.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Cayman Islands in the RBI overseas direct investment dataset (2011–2026).